| dc.contributor.author | Ruf, Benjamin |  | 
| dc.contributor.author | Lauer, Ulrich Manfred |  | 
| dc.date.accessioned | 2017-11-10T14:05:58Z |  | 
| dc.date.available | 2017-11-10T14:05:58Z |  | 
| dc.date.issued | 2015 |  | 
| dc.identifier.issn | 2372-7705 |  | 
| dc.identifier.uri | http://hdl.handle.net/10900/78381 |  | 
| dc.language.iso | en | de_DE | 
| dc.publisher | Nature Publishing Group | de_DE | 
| dc.relation.uri | http://dx.doi.org/10.1038/mto.2015.18 | de_DE | 
| dc.rights | info:eu-repo/semantics/closedAccess |  | 
| dc.subject.ddc | 610 | de_DE | 
| dc.title | Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"? | de_DE | 
| dc.type | Article | de_DE | 
| utue.quellen.id | 20170803141528_00487 |  | 
| utue.personen.roh | Ruf, Benjamin |  | 
| utue.personen.roh | Lauer, Ulrich M. |  | 
| dcterms.isPartOf.ZSTitelID | Molecular Therapy - Oncolytics | de_DE | 
| dcterms.isPartOf.ZS-Issue | Article UNSP 15018 | de_DE | 
| dcterms.isPartOf.ZS-Volume | 2 | de_DE | 
| utue.fakultaet | 04 Medizinische Fakultät | de_DE |